Stifel Financial’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Stifel Financial’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-12,560	Closed	-$968K	–	3338
2021 Q1	$968K	Buy	12,560 +367	+3%	+$33.8K	﹤0.01%	2010
2020 Q4	$1.21M	Buy	12,193 +3,462	+40%	+$423K	﹤0.01%	1715
2020 Q3	$1.24M	Sell	8,731 -15,059	-63%	-$2.51M	﹤0.01%	1490
2020 Q2	$4.69M	Buy	23,790 +664	+3%	+$138K	0.01%	749
2020 Q1	$4.54M	Sell	23,126 -1,688	-7%	-$363K	0.01%	706
2019 Q4	$5.13M	Buy	24,814 +2,984	+14%	+$552K	0.01%	874
2019 Q3	$3.34M	Buy	21,830 +8,984	+70%	+$1.47M	0.01%	1015
2019 Q2	$1.65M	Buy	12,846 +225	+2%	+$26.7K	﹤0.01%	1477
2019 Q1	$1.49M	Buy	12,621 +97	+0.8%	+$9.78K	﹤0.01%	1413
2018 Q4	$1.14M	Sell	12,524 -1,558	-11%	-$158K	﹤0.01%	1452
2018 Q3	$1.57M	Buy	+14,082	New	+$1.49M	﹤0.01%	1400

Other funds holding LKFT

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Stifel Financial's LKFT Position: Q2 2021 in Review

Stifel Financial sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2021, closing a stake of 12,560 shares — an estimated $968K sold.

Stifel Financial first reported a position in LKFT in Q3 2018 and held it in 11 quarters. The position peaked at $5.13M in Q4 2019. 108 funds tracked by Wall St. Rank hold LKFT as of Q2 2021.

Stifel Financial reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Stifel Financial sold 12,560 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2021, an estimated $968K.
Stifel Financial first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2018 and held it in 11 quarters.
Stifel Financial's Lakefront Biotherapeutics American Depositary Shares position peaked at $5.13M in Q4 2019.
108 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2021.

Based on Stifel Financial's 13F filing for Q2 2021, filed 13 Aug 2021.